BioXcel Therapeutics
BTAI
#10060
Rank
HK$78.47 M
Marketcap
HK$14.35
Share price
9.47%
Change (1 day)
-95.77%
Change (1 year)

BioXcel Therapeutics (BTAI) - Cash on Hand

Cash on Hand as of December 2024 : HK$0.23 Billion

According to BioXcel Therapeutics's latest financial reports the company has HK$0.23 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioXcel Therapeutics - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$0.50 B-66.35%
2022-12-31HK$1.51 B-16.68%
2021-12-31HK$1.81 B9.95%
2020-12-31HK$1.65 B554.22%
2019-12-31HK$0.25 B-24.24%
2018-12-31HK$0.33 B4709.78%
2017-12-31HK$6.93 M
2016-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$1.98 B 757.37%๐Ÿ‡บ๐Ÿ‡ธ USA